BETHESDA, MdFour institutions have received SPORE (Specialized Program of Research Excellence) grants from the NCI for ovarian cancer research. The grants, totaling $5.85 million for the first year, went to:
-
The University of Texas M.D. An-derson Cancer Center, to pursue chemo-prevention, antiangiogenesis, and novel treatments for the disease.
-
Fred Hutchinson Cancer Research Center, to establish the Pacific Ovarian Cancer Research Consortium, whose efforts will include studies of genes responsible for resistance to chemotherapy and the development of a nucleic acid vaccine for prevention of the disease.
-
Fox Chase Cancer Center, to develop an interdisciplinary ovarian cancer program focused on carcinogenesis, prevention, and treatment of the cancer.
-
The University of Alabama at Birmingham, for the development of a new genetically engineered monoclonal antibody therapy, targeted immunotherapy, and research to find markers of disease progression that can be used as targets for chemoprevention.
